{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:24:05Z","timestamp":1787883845248,"version":"build-2784847793"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515111144"],"award-info":[{"award-number":["2021A1515111144"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303339"],"award-info":[{"award-number":["82303339"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2021A1515010919"],"award-info":[{"award-number":["2021A1515010919"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003785","name":"Guangdong Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017380","name":"Science and Technology Foundation of Shenzhen City","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017380","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.drup.2024.101116","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T03:33:42Z","timestamp":1719977622000},"page":"101116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["A distinct subset of urothelial cells with enhanced EMT features promotes chemotherapy resistance and cancer recurrence by increasing COL4A1-ITGB1 mediated angiogenesis"],"prefix":"10.1016","volume":"76","author":[{"given":"Jinan","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongcheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinquan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuhua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lipeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoyun","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naikai","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jichao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mou","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2024.101116_bib1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cell.2012.04.042","article-title":"A CXCL1 paracrine network links cancer chemoresistance and metastasis","volume":"150","author":"Acharyya","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.drup.2024.101116_bib2","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1038\/s41467-021-21884-z","article-title":"Single-cell transcriptional changes associated with drug tolerance and response to combination therapies in cancer","volume":"12","author":"Aissa","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2024.101116_bib3","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/bjc.2013.415","article-title":"Stromal disrupting effects of nab-paclitaxel in pancreatic cancer","volume":"109","author":"Alvarez","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.drup.2024.101116_bib4","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1158\/0008-5472.CAN-11-2348","article-title":"p53 inhibits angiogenesis by inducing the production of Arresten","volume":"72","author":"Assadian","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.drup.2024.101116_bib5","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1200\/JCO.2012.42.5215","article-title":"Phase II study of gemcitabine, carboplatin, and bevacizumab in patients with advanced unresectable or metastatic urothelial cancer","volume":"31","author":"Balar","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2024.101116_bib6","doi-asserted-by":"crossref","first-page":"5958","DOI":"10.1158\/0008-5472.CAN-19-0840","article-title":"Cleaved caspase-3 transcriptionally regulates angiogenesis-promoting chemotherapy resistance","volume":"79","author":"Bernard","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.drup.2024.101116_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaa183","article-title":"SingleCellSignalR: inference of intercellular networks from single-cell transcriptomics","volume":"48","author":"Cabello-Aguilar","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drup.2024.101116_bib8","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004994","article-title":"Integrin structure, activation, and interactions","volume":"3","author":"Campbell","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.drup.2024.101116_bib9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ccell.2016.11.010","article-title":"Molecular checkpoint decisions made by subverted vascular niche transform indolent tumor cells into chemoresistant cancer stem cells","volume":"31","author":"Cao","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2024.101116_bib10","doi-asserted-by":"crossref","first-page":"16052","DOI":"10.18632\/oncotarget.14109","article-title":"Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application","volume":"8","author":"Chae","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2024.101116_bib11","article-title":"Mechanisms on chemotherapy resistance of colorectal cancer stem cells and research progress of reverse transformation: A mini-review","volume":"9","author":"Chen","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.drup.2024.101116_bib12","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1038\/s41467-020-18916-5","article-title":"Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma","volume":"11","author":"Chen","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2024.101116_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12916-015-0278-7","article-title":"New horizons in tumor microenvironment biology: challenges and opportunities","volume":"13","author":"Chen","year":"2015","journal-title":"BMC Med."},{"key":"10.1016\/j.drup.2024.101116_bib14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1158\/2159-8274.CD-10-0028","article-title":"Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy","volume":"1","author":"DeNardo","year":"2011","journal-title":"Cancer Discov."},{"key":"10.1016\/j.drup.2024.101116_bib15","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1476-4598-9-152","article-title":"Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer","volume":"9","author":"Dingemans","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2024.101116_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100715","article-title":"Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance","volume":"53","author":"Erin","year":"2020","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.drup.2024.101116_bib17","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumor angiogenesis: therapeutic implications","volume":"285","author":"Folkman","year":"1971","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.drup.2024.101116_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.drup.2018.01.002","article-title":"Redundant angiogenic signaling and tumor drug resistance","volume":"36","author":"Gacche","year":"2018","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.drup.2024.101116_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112424","article-title":"Endothelial cells provide a notch-dependent pro-tumoral niche for enhancing breast cancer survival, stemness and pro-metastatic properties","volume":"9","author":"Ghiabi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.drup.2024.101116_bib20","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.21037\/tau-20-1472","article-title":"Characteristics of upper urinary tract urothelial carcinoma in the context of bladder cancer: a narrative review","volume":"10","author":"Giudici","year":"2021","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.drup.2024.101116_bib21","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature10762","article-title":"Clonal evolution in cancer","volume":"481","author":"Greaves","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.drup.2024.101116_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12943-019-0980-8","article-title":"Extracellular vesicles in the tumor microenvironment: old stories, but new tales","volume":"18","author":"Han","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2024.101116_bib23","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1038\/s41467-019-11721-9","article-title":"Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy","volume":"10","author":"Hong","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2024.101116_bib24","article-title":"Identification of COL4A1 as a potential gene conferring trastuzumab resistance in gastric cancer based on bioinformatics analysis","author":"Huang","year":"2018","journal-title":"Mol. Med Rep. 17, 6387-6396"},{"key":"10.1016\/j.drup.2024.101116_bib25","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.drup.2024.101116_bib26","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1200\/JCO.2006.08.0994","article-title":"Trastuzumab, paclitaxel, carboplatin, and gemcitabine in advanced human epidermal growth factor receptor-2\/neu-positive urothelial carcinoma: results of a multicenter phase II National Cancer Institute trial","volume":"25","author":"Hussain","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2024.101116_bib27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12672-023-00664-9","article-title":"Targeting EFNA1 suppresses tumor progression via the cMYC-modulated cell cycle and autophagy in esophageal squamous cell carcinoma","volume":"14","author":"Jiang","year":"2023","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.drup.2024.101116_bib28","doi-asserted-by":"crossref","first-page":"58172","DOI":"10.18632\/oncotarget.17345","article-title":"The highly expressed COL4A1 genes contributes to the proliferation and migration of the invasive ductal carcinomas","volume":"8","author":"Jin","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2024.101116_bib29","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/jcb.22888","article-title":"Integrin beta1 over-expression associates with resistance to tyrosine kinase inhibitor gefitinib in non-small cell lung cancer","volume":"111","author":"Ju","year":"2010","journal-title":"J. Cell Biochem"},{"key":"10.1016\/j.drup.2024.101116_bib30","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41388-021-02139-z","article-title":"Single-cell RNA-seq recognized the initiator of epithelial ovarian cancer recurrence","volume":"41","author":"Kan","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2024.101116_bib31","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1158\/0008-5472.CAN-12-4502","article-title":"Erlotinib resistance in lung cancer cells mediated by integrin \u03b21\/Src\/Akt-driven bypass signaling","volume":"73","author":"Kanda","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.drup.2024.101116_bib32","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/med.21288","article-title":"FGF receptors: cancer biology and therapeutics","volume":"34","author":"Katoh","year":"2014","journal-title":"Med Res Rev."},{"key":"10.1016\/j.drup.2024.101116_bib33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0945-053X(95)90001-2","article-title":"Basement membrane (type IV) collagen","volume":"14","author":"K\u00fchn","year":"1995","journal-title":"Matrix Biol."},{"key":"10.1016\/j.drup.2024.101116_bib34","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.celrep.2018.10.047","article-title":"Analysis of single-cell rna-seq identifies cell-cell communication associated with tumor characteristics","volume":"25","author":"Kumar","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.drup.2024.101116_bib35","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/ijc.33794","article-title":"Single-cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer","volume":"149","author":"Lai","year":"2021","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.drup.2024.101116_bib36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13073-020-00741-6","article-title":"Single-cell RNA sequencing reveals the tumor microenvironment and facilitates strategic choices to circumvent treatment failure in a chemorefractory bladder cancer patient","volume":"12","author":"Lee","year":"2020","journal-title":"Genome Med"},{"key":"10.1016\/j.drup.2024.101116_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101059","article-title":"Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer","volume":"73","author":"Li","year":"2024","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.drup.2024.101116_bib38","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1038\/s41467-017-02320-7","article-title":"Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer","volume":"8","author":"Liu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2024.101116_bib39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/mco2.55","article-title":"Molecular mechanisms of chemo- and radiotherapy resistance and the potential implications for cancer treatment","volume":"2","author":"Liu","year":"2021","journal-title":"MedComm"},{"key":"10.1016\/j.drup.2024.101116_bib40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ygyno.2014.01.042","article-title":"A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer","volume":"133","author":"Lorusso","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.drup.2024.101116_bib41","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/abbs\/gmab023","article-title":"Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell resistance to cisplatin by regulating miR-34b-5p\/ABCB1 axis","volume":"53","author":"Luo","year":"2021","journal-title":"Acta Biochim Biophys. Sin."},{"key":"10.1016\/j.drup.2024.101116_bib42","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12943-020-01264-9","article-title":"Identification of a distinct luminal subgroup diagnosing and stratifying early stage prostate cancer by tissue-based single-cell RNA sequencing","volume":"19","author":"Ma","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2024.101116_bib43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12943-019-0965-7","article-title":"Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance","volume":"18","author":"Maacha","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2024.101116_bib44","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/avj.12747","article-title":"Tumour angiogenesis, anti-angiogenic therapy and chemotherapeutic resistance","volume":"96","author":"Mander","year":"2018","journal-title":"Aust. Vet. J."},{"key":"10.1016\/j.drup.2024.101116_bib45","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.cell.2020.07.017","article-title":"Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing","volume":"182","author":"Maynard","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.drup.2024.101116_bib46","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00280-020-04222-w","article-title":"Tumor microenvironment promotes breast cancer chemoresistance","volume":"87","author":"Mehraj","year":"2021","journal-title":"Cancer Chemother. Pharm."},{"key":"10.1016\/j.drup.2024.101116_bib47","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1016\/j.ejca.2014.10.013","article-title":"Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma","volume":"50","author":"Milowsky","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.drup.2024.101116_bib48","doi-asserted-by":"crossref","first-page":"36099","DOI":"10.18632\/oncotarget.16432","article-title":"Collagen type IV alpha 1 (COL4A1) and collagen type XIII alpha 1 (COL13A1) produced in cancer cells promote tumor budding at the invasion front in human urothelial carcinoma of the bladder","volume":"8","author":"Miyake","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2024.101116_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101114","article-title":"Cancer plasticity in therapy resistance: mechanisms and novel strategies","author":"Niu","year":"2024","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.drup.2024.101116_bib50","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.cell.2020.05.017","article-title":"Intratumoral CD4(+) T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer.","volume":"181","author":"Oh","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.drup.2024.101116_bib51","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1158\/0008-5472.CAN-05-3523","article-title":"Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts","volume":"66","author":"Paulus","year":"2006","journal-title":"Can. Res"},{"key":"10.1016\/j.drup.2024.101116_bib52","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1016\/S0140-6736(17)32365-6","article-title":"Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial","volume":"390","author":"Petrylak","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.drup.2024.101116_bib53","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1464-410X.2009.09101.x","article-title":"A phase II trial of neoadjuvant erlotinib in patients with muscle-invasive bladder cancer undergoing radical cystectomy: clinical and pathological results","volume":"106","author":"Pruthi","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.drup.2024.101116_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100960","article-title":"Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs","volume":"68","author":"Qi","year":"2023","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.drup.2024.101116_bib55","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tcb.2014.12.006","article-title":"Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance","volume":"25","author":"Seguin","year":"2015","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.drup.2024.101116_bib56","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ctrv.2015.03.004","article-title":"Molecular biology and targeted therapies for urothelial carcinoma","volume":"41","author":"Seront","year":"2015","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.drup.2024.101116_bib57","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4103\/1735-5362.327503","article-title":"Anti-angiogenic peptides application in cancer therapy; a review","volume":"16","author":"Shoari","year":"2021","journal-title":"Res Pharm. Sci."},{"key":"10.1016\/j.drup.2024.101116_bib58","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/wsbm.44","article-title":"The mammalian phenotype ontology: enabling robust annotation and comparative analysis","volume":"1","author":"Smith","year":"2009","journal-title":"Wiley Inter. Rev. Syst. Biol. Med"},{"key":"10.1016\/j.drup.2024.101116_bib59","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive integration of single-cell data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.drup.2024.101116_bib60","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.drup.2024.101116_bib61","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1038\/s41467-021-25624-1","article-title":"Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse","volume":"12","author":"Taavitsainen","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2024.101116_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175991","article-title":"Strategy of targeting the tumor microenvironment via inhibition of fibroblast\/fibrosis remodeling new era to cancer chemo-immunotherapy resistance","volume":"957","author":"Tajaldini","year":"2023","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.drup.2024.101116_bib63","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41571-018-0026-y","article-title":"Treatment resistance in urothelial carcinoma: an evolutionary perspective","volume":"15","author":"Vlachostergios","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.drup.2024.101116_bib64","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5209695","article-title":"Effect of COL4A1 expression on the survival of neoadjuvant chemotherapy breast cancer patients","volume":"2020","author":"Wang","year":"2020","journal-title":"J. Oncol."},{"key":"10.1016\/j.drup.2024.101116_bib65","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1158\/1078-0432.CCR-15-1169","article-title":"Inhibition of the EGFR\/STAT3\/CEBPD axis reverses cisplatin cross-resistance with paclitaxel in the urothelial carcinoma of the urinary bladder","volume":"23","author":"Wang","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2024.101116_bib66","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1158\/1078-0432.CCR-20-4796","article-title":"Single-cell analyses reveal mechanisms of cancer stem cell maintenance and epithelial-mesenchymal transition in recurrent bladder cancer","volume":"27","author":"Wang","year":"2021","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.drup.2024.101116_bib67","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1158\/1078-0432.CCR-11-3127","article-title":"The pivotal role of integrin \u03b21 in metastasis of head and neck squamous cell carcinoma","volume":"18","author":"Wang","year":"2012","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.drup.2024.101116_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100916","article-title":"Overcoming cancer chemotherapy resistance by the induction of ferroptosis","volume":"66","author":"Wang","year":"2023","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.drup.2024.101116_bib69","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7150\/jca.17648","article-title":"Role of tumor microenvironment in tumorigenesis","volume":"8","author":"Wang","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.drup.2024.101116_bib70","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbrc.2018.09.061","article-title":"Integrin \u03b21 promotes gemcitabine resistance in pancreatic cancer through Cdc42 activation of PI3K p110\u03b2 signaling","volume":"505","author":"Yang","year":"2018","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.drup.2024.101116_bib71","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3390\/ijms17091432","article-title":"\u03b21 integrin as a prognostic and predictive marker in triple-negative breast cancer","volume":"17","author":"Yin","year":"2016","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.drup.2024.101116_bib72","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1038\/s41467-023-38833-7","article-title":"NOTCH4(\u0394L12_16) sensitizes lung adenocarcinomas to EGFR-TKIs through transcriptional down-regulation of HES1.","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2024.101116_bib73","article-title":"Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer","volume":"8","author":"Zhang","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.drup.2024.101116_bib74","doi-asserted-by":"crossref","first-page":"D721","DOI":"10.1093\/nar\/gky900","article-title":"CellMarker: a manually curated resource of cell markers in human and mouse","volume":"47","author":"Zhang","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drup.2024.101116_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202003897","article-title":"Single-cell transcriptome analysis uncovers intratumoral heterogeneity and underlying mechanisms for drug resistance in hepatobiliary tumor organoids","volume":"8","author":"Zhao","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.drup.2024.101116_bib76","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s13402-023-00820-x","article-title":"Single-cell RNA sequencing reveals the cellular and molecular characteristics of high-grade and metastatic bladder cancer","volume":"46","author":"Zheng","year":"2023","journal-title":"Cell Oncol."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764624000748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764624000748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T17:06:43Z","timestamp":1778605603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764624000748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":76,"alternative-id":["S1368764624000748"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2024.101116","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A distinct subset of urothelial cells with enhanced EMT features promotes chemotherapy resistance and cancer recurrence by increasing COL4A1-ITGB1 mediated angiogenesis","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2024.101116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101116"}}